Page last updated: 2024-10-22

dan 2163 and Depressive Disorder, Treatment-Resistant

dan 2163 has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research Excerpts

ExcerptRelevanceReference
"Amisulpride (AMS) in low dosage has been used effectively for treatment of dysthymia."2.61Amisulpride as an Augmentation Agent in Treatment Resistant Depression: A Case Series and Review of the Literature. ( Rittmannsberger, H, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rittmannsberger, H1

Reviews

1 review available for dan 2163 and Depressive Disorder, Treatment-Resistant

ArticleYear
Amisulpride as an Augmentation Agent in Treatment Resistant Depression: A Case Series and Review of the Literature.
    Psychiatria Danubina, 2019, Volume: 31, Issue:2

    Topics: Amisulpride; Antidepressive Agents, Second-Generation; Depressive Disorder, Treatment-Resistant; Dru

2019